“life-sciences” Archives

in
Entry Author Date Location
Retrophin Sinks as Drug “Pharma Bro” Martin Shkreli Co-Invented Fails 08/22/19 San Diego
Healthcare’s Future is Telemedicine & AI, But Will Everyone Benefit? 08/22/19 Boston
UniQure Eliminates Chief Operating Officer Role, McMillan to Retire 08/21/19 Boston
Amgen Neuro Exec Marek Joins Axsome as Chief Commercial Officer 08/21/19 New York
Xcelerate at Biotech Week Boston Discount Ticket Sale Ends Friday 08/21/19 National
Oncorus Adds $79.5M to Steer Cancer-Fighting Virus to Human Testing 08/21/19 Boston
Elanco’s $7.6B Deal With Bayer Bolsters Pets, Farm Animals Footprint 08/20/19 Indiana
FDA Rejects Sarepta’s Second Duchenne Drug, Citing Safety Concerns 08/19/19 Boston
Genentech’s Sandra Horning to Retire, Levi Garraway Named Successor 08/19/19 San Francisco
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs 08/16/19 New York
AbbVie’s Successor to Humira Wins FDA OK for Rheumatoid Arthritis 08/16/19 National
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
SpringWorks Therapeutics Appoints Francis Perier CFO 08/15/19 New York
Motif Unveils New Name and $27.5M to Build Food Ingredients Pipeline 08/15/19 Boston
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
Ex-Acceleron Exec Zeldin Named Immunovant Chief Medical Officer 08/14/19 New York
Genomics Experts Preview Xconomy’s Aug. 27 Bay Area Biotech Forum 08/14/19 National
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug 08/13/19 Boston
GSK’s US President Bailey to Depart, EMD Serono Exec Named Successor 08/12/19 National
On Target Laboratories Taps Philips Healthcare’s Barys for CEO 08/12/19 Indiana
Orthofix Medical CEO Mason to Retire, Serbousek Appointed Successor 08/12/19 Texas
Vor Biopharma Appoints Neon’s Robert Ang President & CEO 08/12/19 Boston
Melinta Therapeutics CEO Johnson Resigns, Successor Search Underway 08/09/19 New York
Cleave Therapeutics Appoints Amy Burroughs CEO, Scott Harris COO 08/09/19 San Francisco
Bio Roundup: Surprise News, a Gene Therapy Mess & a CAR-T Step 08/09/19 National
Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work 08/08/19 Boston
Organovo Halts Liver Tissue R&D, Plans Restructuring to Cut Costs 08/07/19 San Diego
Assembly Bio Taps Former Gilead Sciences Exec McHutchison for CEO 08/07/19 San Francisco
Ribon Therapeutics Taps Sudha Parasuraman for Chief Medical Officer 08/07/19 Boston
Rhythm Pharma’s Obesity Drug Hits Phase 3 Goals, FDA Filing Planned 08/07/19 Boston
Page 1 of 396 next page »